Business Description
Theraclion
ISIN : FR0010120402
Share Class Description:
XPAR:ALTHE: Act.Compare
Compare
Traded in other countries / regions
ALTHE.FranceTCLIF.USA IPO Date
2014-04-17Description
Theraclion is a France-based company specializing in high-tech therapeutic ultrasound equipment. The product, Echopulse, helps in the treatment of breast fibroadenomas and benign thyroid nodules.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 4.01 | |||||
Equity-to-Asset | 0.3 | |||||
Debt-to-Equity | 0.35 | |||||
Debt-to-EBITDA | -0.95 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 0.36 | |||||
Beneish M-Score | -0.82 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -6.2 | |||||
3-Year EBITDA Growth Rate | 44.3 | |||||
3-Year EPS without NRI Growth Rate | 29.1 | |||||
3-Year FCF Growth Rate | 36.8 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 47.9 | |||||
9-Day RSI | 44.21 | |||||
14-Day RSI | 42.49 | |||||
6-1 Month Momentum % | -16.84 | |||||
12-1 Month Momentum % | -47.55 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.54 | |||||
Quick Ratio | 2.87 | |||||
Cash Ratio | 1.72 | |||||
Days Inventory | 382.06 | |||||
Days Sales Outstanding | 453.21 | |||||
Days Payable | 244.84 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -41.4 | |||||
Shareholder Yield % | -70.46 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -59.33 | |||||
Operating Margin % | -172.28 | |||||
Net Margin % | -201.7 | |||||
FCF Margin % | -142.54 | |||||
ROE % | -86.5 | |||||
ROA % | -20.62 | |||||
ROIC % | -27.58 | |||||
ROC (Joel Greenblatt) % | -196.25 | |||||
ROCE % | -35.85 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 7.48 | |||||
PB Ratio | 2.41 | |||||
Price-to-Tangible-Book | 2.99 | |||||
EV-to-EBIT | -1.66 | |||||
EV-to-EBITDA | -3.8 | |||||
EV-to-Revenue | 4.28 | |||||
EV-to-FCF | -2.95 | |||||
Price-to-Median-PS-Value | 0.48 | |||||
Price-to-Net-Current-Asset-Value | 4.27 | |||||
Earnings Yield (Greenblatt) % | -60.27 | |||||
FCF Yield % | -19.02 |